Citations

Showing 10 of 108119 citations.

A phase 2, open-label study of rucaparib in patients with pancreatic cancer and a known deleterious BRCA mutation.
Hendifar, Andrew , Shroff, Rachna T. , Leichman, Lawrence P., Epelbaum, Ron, Geva, Ravit , Kim, George P., Wolff, Robert A. , Allen, Andrew R., Giordano, Heidi, Raponi, Mitch , Isaacson, Jeffrey D., Rolfe, Lindsey, Vonderheide, Robert H. , Domchek, Susan M. , McWilliams, Robert R. , Alberts, Steven R. , Biankin, Andrew V.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: TPS4161-TPS4161

10.1200/jco.2014.32.15_suppl.tps4161 Get It

First report of a prospective trial of proton therapy and concomittant capecitabine for patients with nonmetastatic unresectable pancreatic adenocarcinoma.
Nichols, R.C., Morris, Christopher G. , Zaiden, Robert, Ahmed, Bestoun , Ho, Meng Wei , Huh, S.N., George, Thomas J. , Johnson, Elizabeth Anne , Mendenhall, Nancy P. , Hoppe, Bradford S.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e15223-e15223

10.1200/jco.2014.32.15_suppl.e15223 Get It

SWOG S0809: A phase II trial of adjuvant capecitabine (cap)/gemcitabine (gem) followed by concurrent capecitabine and radiotherapy in extrahepatic cholangiocarcinoma (EHCC) and gallbladder carcinoma (GBCA).
Ben‐Josef, Edgar , Guthrie, Katherine A. , Corless, Christopher L. , Zalupski, Mark M. , Lowy, Andrew M. , Thomas, Charles R., Micetich, Kenneth C., Thomas, Melanie B., Siegel, Abby B. , Blanke, Charles D. , El-Khoueiry, Anthony B. , Alberts, Steven R. , Dawson, Laura Ann

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 4030-4030

10.1200/jco.2014.32.15_suppl.4030 Get It

High-grade neuroendocrine carcinoma of the gastrointestinal tract: A retrospective study.
Smyrk, Thomas C. , Chintakuntlawar, Ashish V. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e15152-e15152

10.1200/jco.2014.32.15_suppl.e15152 Get It

A new method to analyze adverse events longitudinally in oncology clinical trials.
Thanarajasingam, Gita , Novotny, Paul J. , Loprinzi, Charles L. , Grothey, Axel, Atherton, Pamela J. , Sloan, Jeff A.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3622-3622

10.1200/jco.2014.32.15_suppl.3622 Get It

Survival following stage II/III colon cancer (CC): Accent-based comparison versus matched general population (MGP).
Renfro, Lindsay A. , Haller, Daniel G. , Loprinzi, Charles L. , Twelves, Chris, Group, Adjuvant Colon Cancer Endpoints (ACCENT), Grothey, Axel , Kerr, David , André, Thierry , Cutsem, Eric Van , Saltz, Leonard B. , Labianca, Roberto , Alberts, Steven R. , Schmoll, Hans‐Joachim , Yothers, Greg , Sargent, Daniel J. , Group, Adjuvant Colon Cancer Endpoints (ACCENT)

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3601-3601

10.1200/jco.2014.32.15_suppl.3601 Get It

Early predictors of improved long-term outcomes in first-line antiangiogenics plus chemotherapy (anti-ANG/CT) in metastatic colorectal cancer (mCRC): Analysis of individual patient (pt) data from the ARCAD database.
Saad, Everardo D. , Coart, Elisabeth , Sommeijer, Dirkje W. , Meyers, Jeffrey P., Hecht, J. Randolph , Hurwitz, Herbert I. , Tol, Jolien , Fuchs, Charles S. , Souglakos, John , Kabbinavar, Fairooz F. , Gramont, Aimery de , Group, for the ARCAD, Shi, Qian , Zalcberg, John , Burzykowski, Tomasz , Hoff, Paulo M. , Tebbutt, Niall C. , Díaz‐Rubio, Eduardo , Falcone, Alfredo , Sargent, Daniel J. , Buyse, Marc , Group, for the ARCAD

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3578-3578

10.1200/jco.2014.32.15_suppl.3578 Get It

Overall survival result and outcomes by KRAS, BRAF, andDNA mismatch repair in relation to primary tumor site in colon cancers from a randomized trial of adjuvant chemotherapy: NCCTG (Alliance) N0147.
Yoon, Harry H. , Mahoney, Michelle R., Nelson, Garth D. , Thibodeau, Stephen N. , Goldberg, Richard M. , Sinicrope, Frank A. , Sargent, Daniel J. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: 3525-3525

10.1200/jco.2014.32.15_suppl.3525 Get It

Variability in calcium/magnesium (CaMg) use for prevention of oxaliplatin-associated neuropathy.
Ruddy, Kathryn J. , Pachman, Dierdre, Haas, Lindsey R., Grothey, Axel, Shah, Nilay D. , Beutler, Andreas S. , Grendahl, Darryl C., Loprinzi, Charles L. , Hubbard, Jacqueline A. , Hubbard, Joleen M.

Mayo Clinic

Journal of Clinical Oncology | January 3, 2019 | Volume: 32 | Issue: 15_suppl | Pages: e14644-e14644

10.1200/jco.2014.32.15_suppl.e14644 Get It